| References |
1. Hameg, A., Bayle, F., Nuss, P., Dupuis, P., Garay, R. P. and Dib, M. (2003)
Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes.
Biochem Pharmacol, 65: 435-440.
[PMID:12527336]
|
2. Knight, A. R., Misra, A., Quirk, K., Benwell, K., Revell, D., Kennett, G. and Bickerdike, M. (2004)
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Naunyn Schmiedebergs Arch Pharmacol, 370: 114-123.
[PMID:15322733]
|
3. Sleight, A. J., Stam, N. J., Mutel, V. and Vanderheyden, P. M. (1996)
Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Biochem Pharmacol, 51: 71-76.
[PMID:8534270]
|
4. Johnson, M. P., Loncharich, R. J., Baez, M. and Nelson, D. L. (1994)
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
Mol Pharmacol, 45: 277-286.
[PMID:8114677]
|
5. Kovacs, A., Gacsalyi, I., Wellmann, J., Schmidt, E., Szucs, Z., Dubreuil, V., Nicolas, J. P., Boutin, J., Bozsing, D., Egyed, A., Tihanyi, K., Spedding, M. and Szenasi, G. (2003)
Effects of EGIS-7625, a selective and competitive 5-HT2B receptor antagonist.
Cardiovasc Drugs Ther, 17: 427-434.
[PMID:15107597]
|
6. Wainscott, D. B., Cohen, M. L., Schenck, K. W., Audia, J. E., Nissen, J. S., Baez, M., Kursar, J. D., Lucaites, V. L. and Nelson, D. L. (1993)
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
Mol Pharmacol, 43: 419-426.
[PMID:8450835]
|
7. Wainscott, D. B., Sasso, D. A., Kursar, J. D., Baez, M., Lucaites, V. L. and Nelson, D. L. (1998)
[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
Naunyn Schmiedebergs Arch Pharmacol, 357: 17-24.
[PMID:9459568]
|
8. Herrick-Davis, K., Egan, C. and Teitler, M. (1997)
Activating mutations of the serotonin 5-HT2C receptor.
J Neurochem, 69: 1138-1144.
[PMID:9282936]
|
9. Monsma, F. J., Shen, Y., Ward, R. P., Hamblin, M. W. and Sibley, D. R. (1993)
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Mol Pharmacol, 43: 320-327.
[PMID:7680751]
|
10. Kohen, R., Metcalf, M. A., Khan, N., Druck, T., Huebner, K., Lachowicz, J. E., Meltzer, H. Y., Sibley, D. R., Roth, B. L. and Hamblin, M. W. (1996)
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
J Neurochem, 66: 47-56.
[PMID:8522988]
|
11. Boess, F. G., Monsma, F. J., Carolo, C., Meyer, V., Rudler, A., Zwingelstein, C. and Sleight, A. J. (1997)
Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells.
Neuropharmacology, 36: 713-720.
[PMID:9225298]
|
12. Boess, F. G., Riemer, C., Bos, M., Bentley, J., Bourson, A. and Sleight, A. J. (1998)
The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum.
Mol Pharmacol, 54: 577-583.
[PMID:9730917]
|
13. Boess, F. G., Monsma, F. J., Meyer, V., Zwingelstein, C. and Sleight, A. J. (1997)
Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor.
Mol Pharmacol, 52: 515-523.
[PMID:9284367]
|
14. Shen, Y., Monsma, F. J., Metcalf, M. A., Jose, P. A., Hamblin, M. W. and Sibley, D. R. (1993)
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
J Biol Chem, 268: 18200-18204.
[PMID:8394362]
|
15. Plassat, J. L., Amlaiky, N. and Hen, R. (1993)
Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.
Mol Pharmacol, 44: 229-236.
[PMID:8394987]
|
16. Krobert, K. A., Bach, T., Syversveen, T., Kvingedal, A. M. and Levy, F. O. (2001)
The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
Naunyn Schmiedebergs Arch Pharmacol, 363: 620-632.
[PMID:11414657]
|
17. Jasper, J. R., Kosaka, A., To, Z. P., Chang, D. J. and Eglen, R. M. (1997)
Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
Br J Pharmacol, 122: 126-132.
[PMID:9298538]
|
18. Bard, J. A., Zgombick, J., Adham, N., Vaysse, P., Branchek, T. A. and Weinshank, R. L. (1993)
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
J Biol Chem, 268: 23422-23426.
[PMID:8226867]
|
19. Thomas, D. R., Gittins, S. A., Collin, L. L., Middlemiss, D. N., Riley, G., Hagan, J., Gloger, I., Ellis, C. E., Forbes, I. T. and Brown, A. M. (1998)
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
Br J Pharmacol, 124: 1300-1306.
[PMID:9720804]
|
|
|